Vertex Pharmaceuticals (WBO:VRTX) Dividends Received


WBO:VRTX Vertex Pharmaceuticals Inc WBO:VRTX
85 GF Score
Price €424.75
GF Value €437.40
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Vertex Pharmaceuticals Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

WBO:VRTX
85GF Score
Vertex Pharmaceuticals Inc WBO:VRTX
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Vertex Pharmaceuticals (WBO:VRTX) Overvalued in 2026?

Based on GuruFocus' analysis, Vertex Pharmaceuticals stock appears to be undervalued. The current stock price of €424.75 is trading 2.9% below its estimated GF Value™ of €437.40. GuruFocus considers Vertex Pharmaceuticals to be Fairly Valued.

Key valuation signals for WBO:VRTX:

  • Dividends Received:
  • GF Value™: €437.40 vs. price of €424.75 (2.9% below fair value)
  • GF Score™: 85/100 with 5 warning signs

No single metric tells the full story. See the WBO:VRTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vertex Pharmaceuticals Business Description

Address 50 Northern Avenue, Boston, MA, USA, 02210
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease, and Journavx, a non-opioid pain medication approved for the treatment of moderate-to-severe acute pain in adults. Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
85GF Score

Get the complete analysis for WBO:VRTX

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€424.75
Price
€437.40
GF Value